TrialDrugs & aging2012

Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly mild to moderate essential hypertensive patients with or without metabolic syndrome: a pooled post hoc analysis of two comparative trials.

Stefano Omboni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.